These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1622396)

  • 21. A new potent calmodulin antagonist with arylalkylamine structure: crystallographic, spectroscopic and functional studies.
    Harmat V; Böcskei Z; Náray-Szabó G; Bata I; Csutor AS; Hermecz I; Arányi P; Szabó B; Liliom K; Vértessy BG; Ovádi J
    J Mol Biol; 2000 Mar; 297(3):747-55. PubMed ID: 10731425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of calmodulin antagonists on lysosomal enzyme secretion and phospholipid metabolism in guinea-pig macrophages.
    Takenawa T; Homma Y; Nagai Y
    Biochem J; 1982 Dec; 208(3):549-58. PubMed ID: 6819863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calmodulin antagonists enhance calcium binding to calmodulin.
    Inagaki M; Tanaka T; Hidaka H
    Pharmacology; 1983; 27(3):125-9. PubMed ID: 6622516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interaction of a new anti-tumour drug, KAR-2 with calmodulin.
    Orosz F; Vértessy BG; Salerno C; Crifo C; Capuozzo E; Ovádi J
    Br J Pharmacol; 1997 Jul; 121(5):955-62. PubMed ID: 9222553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of calmodulin antagonists on immune mouse lymphocytes.
    Wolberg G; Zimmerman TP
    Mol Pharmacol; 1984 Sep; 26(2):286-92. PubMed ID: 6482875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of proteolytic fragments of calmodulin with caldesmon and calponin.
    Medvedeva MV; Kolobova EA; Wang P; Gusev NB
    Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):1021-6. PubMed ID: 8645139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A theoretical study of the binding of phenothiazine derivatives to residues 82-93 of calmodulin.
    Gresh N; Pullman B
    Mol Pharmacol; 1986 Apr; 29(4):355-62. PubMed ID: 3702854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mapping of contact sites in the caldesmon-calmodulin complex.
    Medvedeva MV; Kolobova EA; Huber PA; Fraser ID; Marston SB; Gusev NB
    Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):255-62. PubMed ID: 9164865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional properties of peptides derived from seminalplasmin: binding to monospecific anti-seminalplasmin immunoglobulins G and calmodulin.
    Krauhs E; Preuss KD; Scheit KH
    Biol Chem Hoppe Seyler; 1990 Feb; 371(2):111-6. PubMed ID: 2334517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The calmodulin-binding site of the plasma membrane Ca2+ pump interacts with the transduction domain of the enzyme.
    Falchetto R; Vorherr T; Carafoli E
    Protein Sci; 1992 Dec; 1(12):1613-21. PubMed ID: 1339025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of lanthanum and trifluoperazine on [125I]calmodulin binding to rat striatal particulates.
    Lau YS; Gnegy ME
    J Pharmacol Exp Ther; 1980 Oct; 215(1):28-34. PubMed ID: 7452489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calmodulin antagonists stimulate renin release from isolated rat glomeruli.
    Kawamura M; Inagami T
    Endocrinology; 1983 May; 112(5):1857-9. PubMed ID: 6187563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein binding properties of some histamine H2 antagonists: a 1H nuclear magnetic resonance study of antihistamine-calmodulin interactions.
    Reid DG
    Biochim Biophys Acta; 1986 Apr; 886(1):18-25. PubMed ID: 2869789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of calmodulin in the responses to adrenocorticotropin of plasma membranes from adrenal cells.
    Papadopoulos V; Widmaier EP; Hall PF
    Endocrinology; 1990 May; 126(5):2465-73. PubMed ID: 2158426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel calcium binding protein in Mycobacterium tuberculosis--potential target for trifluoperazine.
    Koul S; Somayajulu A; Advani MJ; Reddy H
    Indian J Exp Biol; 2009 Jun; 47(6):480-8. PubMed ID: 19639701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Target recognition by calmodulin: dissecting the kinetics and affinity of interaction using short peptide sequences.
    Bayley PM; Findlay WA; Martin SR
    Protein Sci; 1996 Jul; 5(7):1215-28. PubMed ID: 8819155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ca2+-bound calmodulin forms a compact globular structure on binding four trifluoperazine molecules in solution.
    Matsushima N; Hayashi N; Jinbo Y; Izumi Y
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):211-5. PubMed ID: 10727421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of cell surface microvilli on rat basophilic leukaemia cells precedes secretion and can be mimicked using the calmodulin antagonist trifluoperazine.
    Edgar AJ; Davies GR; Anwar MA; Bennett JP
    Inflamm Res; 1997 Sep; 46(9):354-60. PubMed ID: 9339391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the efficacy of a phenothiazine and a bisquinaldinium calmodulin antagonist against multidrug-resistant P388 cell lines.
    Hait WN; Pierson NR
    Cancer Res; 1990 Feb; 50(4):1165-9. PubMed ID: 2297765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A model for the regulation of the calmodulin-dependent enzymes erythrocyte Ca2+-transport ATPase and brain phosphodiesterase by activators and inhibitors.
    Gietzen K; Sadorf I; Bader H
    Biochem J; 1982 Dec; 207(3):541-8. PubMed ID: 6299272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.